Mesenchymal Stem Cells for Progressive Multiple Sclerosis_Sweden

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
To assess the safety of a single dose of IV infusion of bone-marrow derived autologous Mesenchymal Stem Cells (MSCs) in Multiple Sclerosis (MS) with progressive disease status.
Epistemonikos ID: b811f6984b4d40e54afbd25b43c6dd23780465f1
First added on: May 21, 2024